Roche Reports Third-Quarter 2026 Sales Results

Roche Holding AG reported its third-quarter 2026 sales results, with the pharmaceutical division surpassing both consensus and analyst estimates, while the diagnostics division fell short of market expectations. The company maintained its full-year financial guidance despite these mixed results. Analysts highlighted that the pharmaceutical division's performance was aided by a one-time inventory effect related to a new ERP system implementation in Japan.